Exodus Point Capital Management, LP Pacific Biosciences Of California, Inc. Transaction History

Exodus Point Capital Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$5.67 - $11.2 $70,381 - $139,025	12,413 New	12,413 $102,000
Q2 2022 Aug 19, 2022	SELL	$4.02 - $10.43 $121,166 - $314,370	-30,141 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$8.43 - $20.9 $168,861 - $418,647	20,031 Added 198.13%	30,141 $274,000
Q4 2021 Feb 11, 2022	BUY	$19.26 - $30.08 $194,718 - $304,108	10,110 New	10,110 $207,000
Q1 2021 May 17, 2021	SELL	$26.38 - $51.15 $2.81 Million - $5.45 Million	-106,454 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$10.5 - $28.5 $1.12 Million - $3.03 Million	106,454 New	106,454 $2.76 Million
Q4 2019 Feb 14, 2020	SELL	$4.6 - $5.57 $47,494 - $57,510	-10,325 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$4.99 - $6.16 $51,521 - $63,602	10,325 New	10,325 $53,000

257

234M

1.02M

965K

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $369M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.